Skip to main content
Fig. 7 | Journal of Hematology & Oncology

Fig. 7

From: Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors

Fig. 7

A proposed study schema of STIE and TIME. The pipeline describes a proposed process of studying STIE and TIME including the different treatment strategies and clinical outcomes. The cross-validation of clinical patients and animal models will clearly reveal the STIE and TIME regulation in the RT and PD-1 inhibitor immunotherapy. As the massive data produced by STIE and TIME study, AI model will assist the analysis of data from an in-house or public research

Back to article page